Skip to main content
Premium Trial:

Request an Annual Quote

Aushon Inks Deal with Peking University to ID Protein Biomarkers for Colorectal Cancer

Premium

Aushon Biosystems this week said it will collaborate with Peking University Cancer Hospital to develop protein biomarkers for the diagnosis of liver metastases of colorectal cancer.

Under the agreement, Aushon will use its protein biomarker detection platform to develop biomarkers to predict liver metastases of colorectal cancer, as well as stratification biomarkers for radio-chemotherapy patients.

The announcement follows on a deal Aushon signed in November with Chinese drug development company LightArray. At that time Aushon CEO Pete Honkanen told ProteoMonitor the agreement would give the company a foothold in the Chinese market, allowing it to take advantage of what it expected would be increasing demand for its products from the country's domestic biotech firms and research organizations (PM 12/03/2010).

Because Chinese regulations forbid sending patient samples out of country, having a domestic laboratory presence is key for biotech companies looking to demonstrate their wares to potential Chinese customers, he noted.

The PUCH collaboration was initiated by the US Chinese Anti-Cancer Association, a non-profit organization of academic, commercial, and government entities launched in 2009 to facilitate collaborations between cancer researchers and physicians in the US and China.

Jin Gu, a professor and clinician at PUCH, will lead the research.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.